BioSapien
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
10210 Campus Point Dr Ste 150, San Diego...Website
www.biosapien.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About BioSapien
BioSapien is dedicated to transforming cancer treatment through its innovative product, MediChip, a localized treatment option that delivers medication directly to tumor sites via a bio-compatible patch. This technology aims to reduce the harsh side effects associated with traditional systemic chemotherapy, improving patients' quality of life during treatment. BioSapien targets a wide range of lower gastrointestinal and solid tumors, with a focus on markets in Europe and the MENA region. The company is backed by leading cancer and surgery specialists and has secured significant funding to advance its mission.Explore more
BioSapien Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BioSapien your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if BioSapien had a recent Job posting/layoffs
Funding: Get notified immidiatlly once BioSapien has new funding data
Check if BioSapien has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on BioSapien recently announced quarterly report
Product Launch: Get notified when BioSapien launches new products
Check out if BioSapien is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at BioSapien
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
BioSapien, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to BioSapien
Compare insights from companies similar to BioSapien, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
BioSapien is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
BioSapien is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BioSapien.
BioSapien financials insights
Gather financial insights about BioSapien, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Angel/Seed
$1.8M
2024
Other Financing Round
$5.5M
BioSapien Tech Stack
A closer look at the technologies used by BioSapien
Most Recent Scoops
Person-Based
Person-Based
Person-Based
Person-Based
Person-Based
BioSapien News & Media
Deals Digest: Middle East startups Huspy, TruKKer, BioSapien raise funds - DealStreetAsia
Huspy, a proptech startup building the largest home-buying platform in Europe and the Middle East, has raised $59 million in a Series B funding round.UAE biotech startup BioSapien raises $7 million pre-Series A for cancer treatment platform
UAE and US-based biotech startup BioSapien has extended its pre-Series A round to $7 million with new investment from Golden Gate Ventures' MENA Fund, marking the fund's first investment in the region, it announced in a statement today. The extension follows the company's initial $5.5 million raise in December led by Global Ventures, with participation from Dara Holdings. Founded in 2018 by Khatija Ali, BioSapien has developed MediChip, a 3D-printed drug delivery platform that enablesUAE-Based BioSapien Secures $5.5 Million to Advance Cancer Treatment - CairoScene
The healthtech company secured pre-Series A funding to advance its 3D-printed MediChip platform for localised cancer treatment.JPIN participates in BioSapien's USD1.8m investment round
JPIN participates in BioSapien's USD1.8m investment round Submitted 15/12/2021 - 1:42pm Startup investment bank for the emerging markets JPIN Venture Catalysts (JPIN) has participated in a USD1.8 million investment round in BioSapien, a biotech that uses 3D Printed Biodegradable mesh designed to deliver cancer drugs directly to tumour sites with greater efficacy and reduced side effects. Joining JPIN in the investment round is the global venture capital investor SOSV, as well as DC Capital Ventu
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioSapien
Sign Up For FreeTo access detailed company insights
BioSapien is dedicated to transforming cancer treatment through its innovative product, MediChip, a localized treatment option that delivers medication directly to tumor sites via a bio-compatible patch. This technology aims to reduce the harsh side effects associated with traditional systemic chemotherapy, improving patients' quality of life durin... Read More
